SCHEMBL19080122

SCHEMBL19080122

c1cc(-c2c3ccccc3c(-c3ccc(-c4ccc5ccccc5c4)cc3)c3ccccc23)cc(-c2cc3ccccc3c3c2oc2c4ccccc4c4ccccc4c23)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 5/20 0.42
ESR1 P03372 4/20 0.35
ESR2 Q92731 4/20 0.35
HSD17B1 P14061 3/20 0.35
HSD17B2 P37059 3/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2B6 P20813 1/20 0.34
CYP2C19 P33261 1/20 0.34
ALOX5 P09917 1/20 0.34
PRKDC P78527 1/20 0.34
GSTP1 P09211 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
MIF P14174 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080010 0.96 GPR84 (0.44) GPR84HSD17B1HSD17B2CYP1A2ALOX5
SCHEMBL19080014 0.85 CYP1A1 (0.40) GPR84ESR1ESR2HSD17B1HSD17B2
SCHEMBL19079999 0.84 GPR84 (0.44) GPR84CYP1A2PRKDCGSTP1KDM4E
SCHEMBL19079980 0.84 ALDH1A1 (0.38) GPR84CYP1A2ALOX5KDM4EMEN1
SCHEMBL19079998 0.84 CYP1A1 (0.41) GPR84ESR1ESR2HSD17B1HSD17B2
SCHEMBL19080000 0.83 CYP1A1 (0.45) GPR84CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL19080108 0.83 ABCG2 (0.43) GPR84CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL19080169 0.83 ALOX5 (0.38) GPR84HSD17B1HSD17B2CYP1A2CYP3A4
SCHEMBL19080044 0.82 ESR1 (0.38) GPR84ESR1ESR2HSD17B1HSD17B2
SCHEMBL10130475 0.82 GPR84 (0.40) GPR84HSD17B1HSD17B2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 GPR84 2425/4885ESR1 153/4885ESR2 510/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 GPR84 2425/4885ESR1 153/4885ESR2 510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.